Treatment with emicizumab improves the health of patients with hemophilia A and inhibitors to Factor VIII, while simultaneously reducing the cost of treatment. These are the findings of the New England Comparative Effectiveness Public Advisory Council (CEPAC), one of the Institute for Clinical and...
Read More... Mar 22, 2018Hemophilia
Hemophilia is the term for a group of blood clotting disorders, characterized by frequent and heavy bleeding. An estimated 20,000 people in the United States have some form of hemophilia, according to figures from the Centers for Disease Control and Prevention (CDC).
There are different forms of hemophilia: hemophilia A occurs when there is an insufficient quantity of the blood clotting factor VIII; hemophilia B is a hereditary condition caused by a lack of blood clotting factor IX; hemophilia C is also caused by a lack of clotting factor IX, and it usually has mild symptoms.
Common signs and symptoms of hemophilia include unexplained or excessive bleeding after surgery or injury, numerous large bruises, blood in the urine or stool, frequent nosebleeds, fatigue, and pain or swelling in the joints. Hemophilia can result in a number of other complications, such as deep internal bleeding, damage to the joints, a higher risk of infection, and adverse reactions to clotting factor treatment.
There is no cure for hemophilia, but treatment may alleviate the symptoms and prevent bleeding episodes. Ongoing treatment often includes infusions with a clotting factor, medication to preserve clots, physical therapy, and vaccinations to prevent against infection. Drug classes commonly used to treat hemophilia include vasopressin (ADH) and analogs, synthetic antifibrinolytics, and blood coagulation factors.
Drugs Used To Treat Hemophilia:
Drugs related to Hemophilia:
Blog Posts Related to Hemophilia:
A new treatment option is available to certain patients with hemophilia A following the US Food and Drug Administration’s (FDA) approval of Genentech’s drug Hemlibra (emicizumab-kxwh). The medication is approved for treatment of patients with hemophilia A who have developed Factor VIII...
Read More... Nov 21, 2017Login or Register to Share!
For every friend or family member you refer you will earn 100 Reward Points on their first prescription purchase! Plus you earn Reward Points on every prescription purchase they make with their ModRN Health card.
You may share without logging in or registering, but please note you will not receive any reward points.